Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody–Positive Patients

Arthritis Care and Research

Volumn 68, Issue 11, 2016, Pages 1655-1663

  Kozora, E ^a,b   Ulug A M ^c,d,e,f   Erkan, D ^b   Vo, A ^c   Filley, C M ^a   Ramon, G ^g   Burleson, A ^h   Zimmerman, R ⁱ   Lockshin, M D ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Cornell University ^*  (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d HOFSTRA UNIVERSITY   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f BOGAZICI UNIVERSITY   (Turkey)

^g HOSPITAL FOR SPECIAL SURGERY   (United States)

^h DEPARTMENT OF MEDICINE   (United States)

ⁱ WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHOTREXATE; MYCOPHENOLATE MOFETIL; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPID ANTIBODY; PREDNISONE; RITUXIMAB; WARFARIN;

ADULT; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITIVE ASSESSMENT; COGNITIVE DEFECT; COMPARATIVE STUDY; CONNECTOME; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; EXECUTIVE DYSFUNCTION; EXECUTIVE FUNCTION; FEMALE; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; MOTOR PERFORMANCE; NEUROIMAGING; PARIETAL CORTEX; PILOT STUDY; SAPPORO CLASSIFICATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TASK PERFORMANCE; TEMPORAL CORTEX; WHITE MATTER CONNECTIVITY; WHITE MATTER INJURY; WORKING MEMORY; ANTIPHOSPHOLIPID SYNDROME; BLOOD; BRAIN; CASE CONTROL STUDY; COGNITIVE DYSFUNCTION; COMPLICATION; DIAGNOSTIC IMAGING; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SHORT TERM MEMORY;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BRAIN; CASE-CONTROL STUDIES; COGNITIVE DYSFUNCTION; EXECUTIVE FUNCTION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84992449512     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22873     Document Type: Article

References (50)

1. American College of Rheumatology. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599–608.
2. Kozora E, Burleson A, Filley C. Neuropsychological functioning in autoimmune disease. In: Morgan J, Ricker J, editors. Clinical neuropsychology, 2nd ed. New York: Taylor and Francis Group, In press.
3. Aisen AM, Gabrielsen TO, McCune WJ. MR imaging of systemic lupus erythematosus involving the brain. Am J Roentgenol 1985;144:1027–31.
4. Davie CA, Feinstein A, Kartsounis LD, Barker GJ, McHugh NJ, Walport MJ, et al. Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system. J Neurol 1995;242:522–8.
5. Fields RA, Sibbitt WL, Toubbeh H, Bankhurst AD. Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies. Ann Rheum Dis 1990;49:114–7.
6. Ishikawa O, Ohnishi K, Miyachi Y, Ishizaka H. Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging: relationship to anticardiolipin antibody. J Rheumatol 1994;21:87–90.
7. Kozora E, West SG, Kotzin BL, Julian L, Porter S, Bigler E. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1998;41:41–7.
8. Jarek MJ, West SG, Baker MR, Rak KM. Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus. Arthritis Rheum 1994;37:1609–13.
9. Gonzalez-Crespo MR, Blanco FJ, Ramos A, Ciruelo E, Mateo I, Lopez-Pino MA, et al. Magnetic resonance imaging of the brain in systemic lupus erythematosus. Br J Rheumatology 1995;34:1055–60.
10. DiFrancesco MW, Holland SK, Ris MD, Adler CM, Nelson S, DelBello MP, et al. Functional magnetic resonance imaging assessment of cognitive function in childhood-onset systemic lupus erythematosus: a pilot study. Arthritis Rheum 2007;56:4151–63.
11. Fitzgibbon BM, Fairhall SL, Kirk IJ, Kalev-Zylinska M, Pui K, Dalbeth N, et al. Functional MRI in NPSLE patients reveals increased parietal and frontal brain activation during a working memory task compared with controls. Rheumatology (Oxford) 2008;47:50–3.
12. Mak A, Ren T, Fu E, Cheak A, Ho R. A prospective functional MRI study for executive function in patients with systemic lupus erythematosus without neuropsychiatric symptoms. Semin Arthritis Rheum 2012;41:849–58.
13. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295–306.
14. Sanna G, Bertolaccini ML, Cuadrado MJ, Liang H, Khamashta MA, Mathieu A, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003;30:985–92.
15. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019–27.
16. Roldan JF, Brey RL. Neurologic manifestations of the antiphospholipid syndrome. Curr Rheumatol Rep 2007;9:109–15.
17. Chapman J, Abu-Katash M, Inzelberg R, Yust I, Neufeld MY, Vardinon N, et al. Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants. J Neurol Sci 2002;203:81–4.
18. Jacobson MW, Rapport LJ, Keenan PA, Coleman RD, Tietjen GE. Neuropsychological deficits associated with antiphospholipid antibodies. J Clin Exp Neuropsychol 1999;21:251–64.
19. Tektonidou MG, Varsou N, Kotoulas G, Antoniou A, Moutsopoulos HM. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med 2006;166:2278–84.
20. Gomez-Puerta JA, Cervera R, Calvo LM, Gomez-Anson B, Espinosa G, Claver G, et al. Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients. Rheumatology (Oxford) 2005;44:95–9.
21. Provenzale JM, Barboriak DP, Allen NB, Ortel TL. Patients with antiphospholipid antibodies: CT and MR findings of the brain. AJR Am J Roentgenol 1996;167:1573–8.
22. Kozora E, Erkan D, Zimmerman R, Ramon G, Ulug A, Lockshin M. Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients. Clin Exp Rheum 2014;32:34–40.
23. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
24. First MB, Spitzer RL, Gibbon M, Williams JB. Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV). Washington (DC): American Psychiatric Press; 1996.
25. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630–40.
26. Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 1996;5:190–5.
27. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, et al, The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993;86:447–58.
28. Symmons DP, Coppock JS, Bacon PA, Bresnihan B, Isenberg DA, Maddison P, et al, and Members of the British Isles Lupus Assessment Group (BILAG). Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Q J Med 1988;69:927–37.
29. Kozora E, Thompson LL, West SG, Kotzin BL. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996;39:2035–45.
30. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories IA and II in psychiatric outpatients. J Pers Assess 1996;67:588–97.
31. Walecki J, Trawinski Z, Rozyczka I, Raczka Z. Use of the transcranial Doppler ultrasonographic diagnosis in neurology and surgery. Pol Tyg Lek 1992;47:463–5. In Polish.
32. Friston K, Holmes A, Worsley K, Poline J, Frith C, Frackowiak R. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Map 1995;2:189–210.
33. Carlson S, Martinkauppi S, Rama P, Salli E, Korvenoja A, Aronen HJ. Distribution of cortical activation during visuospatial n-back tasks as revealed by functional magnetic resonance imaging. Cereb Cortex 1998;8:743–52.
34. Gevins AS, Morgan NH, Bressler SL, Cutillo BA, White RM, Illes J, et al. Human neuroelectric patterns predict performance accuracy. Science 1987;235:580–5.
35. Parmenter BA, Shucard JL, Benedict RH, Shucard DW. Working memory deficits in multiple sclerosis: comparison between the n-back task and the Paced Auditory Serial Addition Test. J Int Neuropsychol Soc 2006;12:677–87.
36. Segalowitz SJ, Wintink AJ, Cudmore LJ. P3 topographical change with task familiarization and task complexity. Brain Res Cogn Brain Res 2001;12:451–7.
37. Kozora E, Ellison MC, West S. Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus. Arthritis Rheum 2004;51:810–8.
38. Kozora E, Arciniegas D, Duggan E, West S, Brown M, Filley C. White matter abnormalities and working memory impairment in systemic lupus erythematosus. Cognit Behav Neurol 2013;26:63–72.
39. Rocca MA, Agosta F, Mezzapesa DM, Ciboddo G, Falini A, Comi G, et al. An fMRI study of the motor system in patients with neuropsychiatric systemic lupus erythematosus. Neuroimage 2006;30:478–84.
40. Kozora E, West SG, Kotzin BL, Julian L, Porter S, Bigler E. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1998;41:41–7.
41. Filley CM, Kozora E, Brown MS, Miller DE, West SG, Arciniegas DB, et al. White matter microstructure and cognition in non-neuropsychiatric systemic lupus erytematosus. Cogn Behav Neurol 2009;22:38–44.
42. Lin Y, Zou Q, Wang J, Wang Y, Zhou D, Zhang R, et al. Localization of cerebral functional deficits in patients with non-neuropsychiatric systemic lupus erythematosus. Hum Brain Mapp 2011;32:1847–55.
43. Mackay M, Bussa M, Aranow C, Ulug A, Volpe B, Huerta P, et al. Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration. Mol Med 2011;17:1349–56.
44. Daselaar S, Iyengar V, Davis S, Eklund K, Hayes S, Cabeza R. Less wiring, more firing: low-performing older adults compensate for impaired white matter with greater neural activity. Cereb Cortex 2015;4:983–90.
45. Kozora E, Filley CM. Cognitive dysfunction and white matter abnormalities in systemic lupus erythematosus. J Int Neuropsychol Soc 2011;17:385–92.
46. Kozora E, West SG, Maier SF, Filley CM, Arciniegas DB, Brown M, et al. Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. J Neurol Sci 2010;295:87–91.
47. Kozora E, Filley C, Zhang L, Brown M, Miller DE, Arciniegas DB, et al. Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations. Lupus 2012;21:402–11.
48. Trysberg E, Carlsten H, Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 2000;9:498–503.
49. Okamoto H, Kobayashi A, Yamanaka H. Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus. J Biomed Biotech 2010;2010:268436.
50. Lu XY, Zhu CQ, Qian J, Chen XX, Ye S, Gu YY. Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection. Lupus 2010;19:689–95.